Utilization and Costs of Gender-Affirming Care in a Commercially Insured Transgender Population.


Journal

The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics
ISSN: 1748-720X
Titre abrégé: J Law Med Ethics
Pays: England
ID NLM: 9315583

Informations de publication

Date de publication:
2022
Historique:
entrez: 18 11 2022
pubmed: 19 11 2022
medline: 22 11 2022
Statut: ppublish

Résumé

Many transgender people need specific medical services to affirm their gender. Gender-affirming health care services may include mental health support, hormone therapy, and reconstructive surgeries. Scant information is available about the utilization or costs of these services among transgender people, which hinders the ability of insurance regulators, health plans, and other health care organizations to plan and budget for the health care needs of this population and to ensure that transgender people can access medically necessary gender-affirming care. This study used almost three decades of commercial insurance claims from a proprietary database containing data on more than 200 million people to identify temporal trends in the provision of gender-affirming hormone therapy and surgeries and to quantify the costs of these services.

Identifiants

pubmed: 36398652
doi: 10.1017/jme.2022.87
pii: S1073110522000870
pmc: PMC9679590
doi:

Substances chimiques

Hormones 0

Types de publication

Journal Article

Langues

eng

Pagination

456-470

Subventions

Organisme : NIAID NIH HHS
ID : T32 AI102623
Pays : United States

Références

J Clin Endocrinol Metab. 2017 Nov 1;102(11):3869-3903
pubmed: 28945902
J Acquir Immune Defic Syndr. 2016 Aug 15;72 Suppl 3:S235-42
pubmed: 27429189
LGBT Health. 2017 Aug;4(4):244-247
pubmed: 28708447
Transgend Health. 2019 Apr 11;4(1):131-135
pubmed: 31289750
LGBT Health. 2017 Jun;4(3):188-193
pubmed: 28402749
Int J Transgend. 2019;20(1):49-62
pubmed: 31217753
LGBT Health. 2019 May/Jun;6(4):166-173
pubmed: 31084519
LGBT Health. 2014 Dec;1(4):269-76
pubmed: 26789855
Endocrinol Metab Clin North Am. 2019 Jun;48(2):303-321
pubmed: 31027541
LGBT Health. 2020 Apr;7(3):137-145
pubmed: 32267818
Health Serv Res. 2004 Dec;39(6 Pt 1):1839-57
pubmed: 15533190
Transgend Health. 2019 Aug 07;4(1):162-167
pubmed: 31482132
Transgend Health. 2016 Jan;1(1):21-31
pubmed: 27595141
Proc Natl Acad Sci U S A. 2019 Dec 3;116(49):24480-24485
pubmed: 31740598
J Am Med Inform Assoc. 2018 Jul 1;25(7):905-908
pubmed: 29635362
J Gen Intern Med. 2016 Apr;31(4):394-401
pubmed: 26481647
Endocr Pract. 2017 Jul;23(7):780-786
pubmed: 28448757
Int Rev Psychiatry. 2012 Dec;24(6):568-77
pubmed: 23244612
Int J Transgend Health. 2022 Sep 6;23(Suppl 1):S1-S259
pubmed: 36238954

Auteurs

Kellan Baker (K)

WHITMAN-WALKER INSTITUTE, WASHINGTON, DC, USA.
JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH, BALTIMORE, MD, USA.

Arjee Restar (A)

CENTER FOR APPLIED TRANSGENDER STUDIES, CHICAGO, IL, USA.
UNIVERSITY OF WASHINGTON, SEATTLE, WA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH